Загрузка...
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
In the context of an increasing repertoire of multiple sclerosis (MS) therapeutics, choosing the appropriate treatment for an individual patient is becoming increasingly challenging. Natalizumab, a humanized monoclonal antibody directed against alpha4beta1 integrin, has proven short-term and long-te...
Сохранить в:
| Опубликовано в: : | Patient Prefer Adherence |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446014/ https://ncbi.nlm.nih.gov/pubmed/26056435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S20791 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|